Three recent studies, including one by our group, have described several genetic hallmarks of FHRCC, including a characteristically low tumor mutation burden, distinct tumor microenvironments characterized by CD8+ T-cell infiltration with PD-L1 expression in tumors, and a highly depleted and mutant mitochondrial genome [7,12,13]. This evidence concerns the gene CD8A and neoplasm.